Chinese state-owned enterprises’ acquisition of Australia’s third-largest vitamins firm by sales reflects the country’s hunger for food safety – but not at any price.

Buying Australia’s leading health supplement brand matches Fosun’s global ambitions — and could also help the target boost its China sales.

China’s drive to improve food safety via foreign acquisitions faces growing anti-trust barriers and management failures. FinanceAsia talks to deal-makers about how to make the recipe just right.

The private equity firm’s sale of its China Modern Dairy stake is nicely timed as it raises funds. But for buyer Mengnui the deal poses considerable integration risk.

Kate Richdale and Andrea Vella talk about how they are reshaping the firm, the thinking behind recent layoffs and their top insights into 2017 corporate finance trends.

The Chinese pharmaceutical firm offers $238 million to take Vitaco private, in the latest example of China’s huge interest in clean and green food products.

Generic drug manufacturer takes advantage of rising order books for Indian high-yield deals to price significantly through many brokers' fair value estimates.

FinanceAsia is pleased to reveal the detailed rationale for the winners of its International Banking Awards 2016.

Two Chinese companies from either end of the credit spectrum jump into the market after the Fed's dovish policy statement.

Chinese infant formula manufacturer is looking to make its debut international bond offering to partially finance the repurchase of its outstanding convertible debt.